Mouse models for HIV-1 infection

被引:11
作者
Borkow, G [1 ]
机构
[1] Cupron Inc, IL-76910 Kfar Gibton, Israel
关键词
mouse HIV-1 models; vaccine development;
D O I
10.1080/15216540500459642
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The generation of small animal models, which preserve the ability for the generation of primary and memory immune responses of the engrafted human immune cells and in which a robust HIV-1 infection may occur, may enable the rapid screening, development and evaluation of HIV-1 protective vaccines and adjuvants. This manuscript reviews the existing mouse HIV-1 models used to study virologic, immunologic and pathogenic aspects of HIV-1 infection and disease and discusses their limitations and advantages, especially in the context of vaccine development, with special focus on the recently developed Trimera-HIV-1 animal model.
引用
收藏
页码:819 / 823
页数:5
相关论文
共 37 条
[1]   A novel small animal model for HIV-1 infection [J].
Ayash-Rashkovsky, M ;
Bentwich, Z ;
Arditti, F ;
Friedman, S ;
Reisner, Y ;
Borkow, G .
FASEB JOURNAL, 2005, 19 (06) :1149-+
[2]   Enhanced HIV-1 specific immune response by CpG ODN and HIV-1 immunogen-pulsed dendritic cells confers protection in the Trimera murine model of HIV-1 infection [J].
Ayash-Rashkovsky, M ;
Borkow, G ;
Davis, HL ;
Moss, RB ;
Bartholomew, R ;
Bentwich, Z .
FASEB JOURNAL, 2005, 19 (06) :1152-+
[3]   TLR9 expression is related to immune activation but is impaired in individuals with chronic immune activation [J].
Ayash-Rashkovsky, M ;
Bentwich, Z ;
Borkow, G .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (11) :2380-2394
[4]   RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model [J].
Bai, JR ;
Banda, N ;
Lee, NS ;
Rossi, J ;
Akkina, R .
MOLECULAR THERAPY, 2002, 6 (06) :770-782
[5]   Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection [J].
Ben-Yedidia, T ;
Marcus, H ;
Reisner, Y ;
Arnon, R .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (07) :1043-1051
[6]   A promising model of primary human immunization in human-scid mouse [J].
Bombil, F ;
Kints, JP ;
Scheiff, JM ;
Bazin, H ;
Latinne, D .
IMMUNOBIOLOGY, 1996, 195 (03) :360-375
[7]   Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries [J].
Borkow, G ;
Bentwich, Z .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (03) :505-507
[8]  
Delhem N, 1998, J IMMUNOL, V161, P2060
[9]   Limits of the human-PBL-SCID mice model: Severe restriction of the V beta T-cell repertoire of engrafted human T cells [J].
Garcia, S ;
Dadaglio, G ;
Gougeon, ML .
BLOOD, 1997, 89 (01) :329-336
[10]   Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challenge [J].
Gorantla, S ;
Santos, K ;
Meyer, V ;
Dewhurst, S ;
Bowers, WJ ;
Federoff, HJ ;
Gendelman, HE ;
Poluektova, L .
JOURNAL OF VIROLOGY, 2005, 79 (04) :2124-2132